These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The preferential antagonism of pentylenetetrazole proconflict responses differentiates a class of anxiolytic benzodiazepines with potential antipanic action. Giusti P; Guidetti G; Costa E; Guidotti A J Pharmacol Exp Ther; 1991 Jun; 257(3):1062-8. PubMed ID: 1675286 [TBL] [Abstract][Full Text] [Related]
23. Oxidative metabolism of limbic structures after acute administration of diazepam, alprazolam and zolpidem. González-Pardo H; Conejo NM; Arias JL Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1020-6. PubMed ID: 16647177 [TBL] [Abstract][Full Text] [Related]
24. Comparison of the spectrum of cognitive effects of alprazolam and adinazolam after single doses in healthy subjects. Fleishaker JC; Garzone PD; Chambers JH; Sirocco K; Weingartner H Psychopharmacology (Berl); 1995 Jul; 120(2):169-76. PubMed ID: 7480549 [TBL] [Abstract][Full Text] [Related]
25. Behavioural pharmacology of benzodiazepines. File SE Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(1):19-31. PubMed ID: 6145185 [TBL] [Abstract][Full Text] [Related]
26. Anxiolytic-like effect of 5-HT(2) ligands and benzodiazepines co-administration: comparison of two animal models of anxiety (the four-plate test and the elevated plus maze). Massé F; Nic Dhonnchadha BA; Hascoët M; Bourin M Behav Brain Res; 2007 Feb; 177(2):214-26. PubMed ID: 17175036 [TBL] [Abstract][Full Text] [Related]
27. Differential effects of six structurally related benzodiazepines on some ethological measures of timidity, aggression and locomotion in mice. Krsiak M; Sulcova A Psychopharmacology (Berl); 1990; 101(3):396-402. PubMed ID: 1972998 [TBL] [Abstract][Full Text] [Related]
28. Comparison of the predictive validity of the mirror chamber and elevated plus maze tests in mice. Paterson NE; Iwunze M; Davis SF; Malekiani SA; Hanania T J Neurosci Methods; 2010 Apr; 188(1):62-70. PubMed ID: 20149823 [TBL] [Abstract][Full Text] [Related]
29. The behavioural properties of CI-988, a selective cholecystokininB receptor antagonist. Singh L; Field MJ; Hughes J; Menzies R; Oles RJ; Vass CA; Woodruff GN Br J Pharmacol; 1991 Sep; 104(1):239-45. PubMed ID: 1686205 [TBL] [Abstract][Full Text] [Related]
30. Comparison of benzodiazepines and the non-benzodiazepine agents zolpidem and zaleplon with respect to anxiolytic action as measured by increases in hypertonic NaCl-solution drinking in rats. Lobarinas E; Falk JL Psychopharmacology (Berl); 2000 Apr; 149(2):176-80. PubMed ID: 10805613 [TBL] [Abstract][Full Text] [Related]
31. Behavioral effects of acute and chronic oral administration of barakol in rats. Deachapunya C; Thongsaard W J Med Assoc Thai; 2009 Jun; 92 Suppl 3():S29-37. PubMed ID: 19702066 [TBL] [Abstract][Full Text] [Related]
32. Pharmacological profile of the antidepressant adinazolam, a triazolobenzodiazepine. Lahti RA; Sethy VH; Barsuhn C; Hester JB Neuropharmacology; 1983 Nov; 22(11):1277-82. PubMed ID: 6320036 [TBL] [Abstract][Full Text] [Related]
33. Lack of cross-tolerance in mice between the stimulatory and depressant actions of novel anxiolytics in the holeboard. Pellow S; File SE Behav Brain Res; 1987 Feb; 23(2):159-66. PubMed ID: 2882763 [TBL] [Abstract][Full Text] [Related]
34. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Prut L; Belzung C Eur J Pharmacol; 2003 Feb; 463(1-3):3-33. PubMed ID: 12600700 [TBL] [Abstract][Full Text] [Related]
35. Characterization of the anxiolytic and sedative profile of JM-20: a novel benzodiazepine-dihydropyridine hybrid molecule. Figueredo YN; Rodríguez EO; Reyes YV; Domínguez CC; Parra AL; Sánchez JR; Hernández RD; Verdecia MP; Pardo Andreu GL Neurol Res; 2013 Oct; 35(8):804-12. PubMed ID: 23651620 [TBL] [Abstract][Full Text] [Related]
36. Comparison of behavioral effects after single and repeated administrations of four benzodiazepines in three mice behavioral models. Bourin M; Hascoet M; Mansouri B; Colombel MC; Bradwejn J J Psychiatry Neurosci; 1992 Jun; 17(2):72-7. PubMed ID: 1637802 [TBL] [Abstract][Full Text] [Related]
37. RP 59037 and RP 60503: anxiolytic cyclopyrrolone derivatives with low sedative potential. interaction with the gamma-aminobutyric acidA/benzodiazepine receptor complex and behavioral effects in the rodent. Doble A; Canton T; Dreisler S; Piot O; Boireau A; Stutzmann JM; Bardone MC; Rataud J; Roux M; Roussel G J Pharmacol Exp Ther; 1993 Sep; 266(3):1213-26. PubMed ID: 8103792 [TBL] [Abstract][Full Text] [Related]
38. Sedative and anxiolytic potency of benzodiazepines: some structure-activity relationships. Krsiak M; Sulcová A Act Nerv Super (Praha); 1989 Apr; 31(1):59-61. PubMed ID: 2571229 [No Abstract] [Full Text] [Related]